一种通过引入赋予链霉素抗性的rpsL（编码核糖体蛋白S12）突变来改良天蓝色链霉菌A3(2)以生产放线紫红素的新方法。 - Suppr

Suppr

超能文献

A novel method for improving Streptomyces coelicolor A3(2) for production of actinorhodin by introduction of rpsL (encoding ribosomal protein S12) mutations conferring resistance to streptomycin.

作者信息

Hesketh A, Ochi K

出版信息

J Antibiot (Tokyo). 1997 Jun;50(6):532-5. doi: 10.7164/antibiotics.50.532.

DOI:10.7164/antibiotics.50.532

PMID:9268013

Abstract

摘要

相似文献

A novel method for improving Streptomyces coelicolor A3(2) for production of actinorhodin by introduction of rpsL (encoding ribosomal protein S12) mutations conferring resistance to streptomycin.一种通过引入赋予链霉素抗性的rpsL（编码核糖体蛋白S12）突变来改良天蓝色链霉菌A3(2)以生产放线紫红素的新方法。

J Antibiot (Tokyo). 1997 Jun;50(6):532-5. doi: 10.7164/antibiotics.50.532.

Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2).在淡紫灰链霉菌和天蓝色链霉菌A3(2)中，赋予链霉素抗性的rpsL（编码核糖体蛋白S12）突变诱导放线紫红素的产生。

J Bacteriol. 1996 Dec;178(24):7276-84. doi: 10.1128/jb.178.24.7276-7284.1996.

An aberrant protein synthesis activity is linked with antibiotic overproduction in rpsL mutants of Streptomyces coelicolor A3(2).在天蓝色链霉菌A3(2)的rpsL突变体中，异常的蛋白质合成活性与抗生素过量产生有关。

Microbiology (Reading). 2003 Nov;149(Pt 11):3299-3309. doi: 10.1099/mic.0.26490-0.

Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations.通过诱导联合抗性突变提高抗生素生产菌株生产力的新方法。

Appl Environ Microbiol. 2001 Apr;67(4):1885-92. doi: 10.1128/AEM.67.4.1885-1892.2001.

Molecular and functional analysis of the ribosomal L11 and S12 protein genes (rplK and rpsL) of Streptomyces coelicolor A3(2).天蓝色链霉菌A3(2)核糖体L11和S12蛋白基因（rplK和rpsL）的分子与功能分析

Mol Gen Genet. 1997 Nov;256(5):488-98. doi: 10.1007/pl00008614.

Development of antibiotic-overproducing strains by site-directed mutagenesis of the rpsL gene in Streptomyces lividans.通过对变铅青链霉菌rpsL基因进行定点诱变开发抗生素高产菌株。

Appl Environ Microbiol. 2003 Jul;69(7):4256-9. doi: 10.1128/AEM.69.7.4256-4259.2003.

Genetically engineered rpsL merodiploidy impacts secondary metabolism and antibiotic resistance in Streptomyces.基因工程 rpsL 部分二倍体影响链霉菌的次生代谢和抗生素抗性。

World J Microbiol Biotechnol. 2021 Mar 17;37(4):62. doi: 10.1007/s11274-021-03030-5.

Resistance to paromomycin is conferred by rpsL mutations, accompanied by an enhanced antibiotic production in Streptomyces coelicolor A3(2).在天蓝色链霉菌A3(2)中，rpsL突变赋予了对巴龙霉素的抗性，并伴随着抗生素产量的增加。

J Antibiot (Tokyo). 2000 Dec;53(12):1424-7. doi: 10.7164/antibiotics.53.1424.

Mutations in rsmG, encoding a 16S rRNA methyltransferase, result in low-level streptomycin resistance and antibiotic overproduction in Streptomyces coelicolor A3(2).编码16S rRNA甲基转移酶的rsmG基因突变，会导致天蓝色链霉菌A3(2)产生低水平链霉素抗性和抗生素过量生产。

J Bacteriol. 2007 May;189(10):3876-83. doi: 10.1128/JB.01776-06. Epub 2007 Mar 23.

Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations.天蓝色链霉菌中累积的耐药性突变对抗生素生产的显著激活作用。

Appl Environ Microbiol. 2008 May;74(9):2834-40. doi: 10.1128/AEM.02800-07. Epub 2008 Feb 29.

引用本文的文献

Small molecule inducers of actinobacteria natural product biosynthesis.小分子诱导抗生素生物合成。

J Ind Microbiol Biotechnol. 2023 Feb 17;50(1). doi: 10.1093/jimb/kuad019.

Novel Fredericamycin Variant Overproduced by a Streptomycin-resistant subsp. Strain.新型弗德里卡霉素变体由链霉素抗性亚种菌株过量生产。

Mar Drugs. 2020 May 28;18(6):284. doi: 10.3390/md18060284.

The Application of Ribosome Engineering to Natural Product Discovery and Yield Improvement in .核糖体工程在天然产物发现及产量提高中的应用。（注：原文句末不完整，推测可能遗漏了相关具体内容）

Antibiotics (Basel). 2019 Aug 30;8(3):133. doi: 10.3390/antibiotics8030133.

Identification of a Novel Lincomycin Resistance Mutation Associated with Activation of Antibiotic Production in Streptomyces coelicolor A3(2).在天蓝色链霉菌A3(2)中鉴定出一种与抗生素产生激活相关的新型林可霉素抗性突变。

Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.02247-16. Print 2017 Feb.

Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects.微生物隐秘基因激活与菌株改良的见解：原理、应用及技术层面

J Antibiot (Tokyo). 2017 Jan;70(1):25-40. doi: 10.1038/ja.2016.82. Epub 2016 Jul 6.

Discovery of cahuitamycins as biofilm inhibitors derived from a convergent biosynthetic pathway.发现源自汇聚生物合成途径的卡胡他霉素作为生物膜抑制剂。

Nat Commun. 2016 Feb 16;7:10710. doi: 10.1038/ncomms10710.

Combinatorial approaches for inverse metabolic engineering applications.用于逆向代谢工程应用的组合方法。

Comput Struct Biotechnol J. 2013 Mar 11;3:e201210021. doi: 10.5936/csbj.201210021. eCollection 2012.

Identification of two novel anti-fibrotic benzopyran compounds produced by engineered strains derived from Streptomyces xiamenensis M1-94P that originated from deep-sea sediments.从深海沉积物中分离的厦门链霉菌 M1-94P 工程菌株产生的两种新型抗纤维化苯并吡喃化合物的鉴定。

Mar Drugs. 2013 Oct 22;11(10):4035-49. doi: 10.3390/md11104035.

Disruption of rimP-SC, encoding a ribosome assembly cofactor, markedly enhances the production of several antibiotics in Streptomyces coelicolor.破坏 rimP-SC（编码核糖体组装辅助因子）可显著提高变铅青链霉菌中几种抗生素的产量。

Microb Cell Fact. 2013 Jul 2;12:65. doi: 10.1186/1475-2859-12-65.

New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters.新药发现策略：激活沉默或弱表达的微生物基因簇。

Appl Microbiol Biotechnol. 2013 Jan;97(1):87-98. doi: 10.1007/s00253-012-4551-9. Epub 2012 Nov 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验